Novavax inventory doubles after Sanofi deal marks 'new bankruptcy' for corporate
Novavax inventory (NVAX) skyrocketed on Friday, just about doubling at the information French drug and vaccine large Sanofi (SNY) would make investments $1.2 billion in a deal for Novavax’s COVID-19 vaccine and